跳至主要内容
临床试验/NCT04278573
NCT04278573已完成2 期

Efficacy of Intralesional Vitamin D Injection for Treatment of Common Warts: A Randomized Controlled Trial

Stephen P. Merry1 个研究点 分布在 1 个国家目标入组 77 人开始时间: 2020年10月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
77
试验地点
1
主要终点
Complete Regression of Wart

研究概览

简要总结

Researchers are trying to find out if injecting Vitamin D into a wart is an effective treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients seen at the Mayo Clinic Rochester practices
  • Patients suffering from one or more cutaneous warts as diagnosed by the examining physician at baseline visit on typical diagnostic characteristics
  • Able to provide consent
  • Both recalcitrant and non-recalcitrant warts will be included

排除标准

  • Patients with prior use of home or office-based destructive treatments for this wart(s) in the last 1 month with salicylic acid (SA) or cryotherapy
  • Immunoadjuvant therapy for warts in the last 4 months (e.g Candida)
  • History of vitamin D injection of warts ever
  • High-dose vitamin D supplementation (>4,000 IU daily or equivalent) in the preceding 3 months
  • Pregnancy or lactation
  • Facial or genital warts
  • Lesions not felt by the examining clinician to be a wart (e.g., corns or calluses)
  • Immunosuppression (to include immunosuppressive medications or conditions as judged by the physician evaluating the patient at the baseline visit).
  • Allergy to sesame oil

研究组 & 干预措施

Vitamin D3 Treatment Group

Experimental

Subjects will receive a Vitamin D3 injection into their wart

干预措施: Vitamin D3 (Drug)

Placebo Group

Placebo Comparator

Subjects will receive a placebo injection into their wart

干预措施: Placebo (Drug)

结局指标

主要结局

Complete Regression of Wart

时间窗: 24 weeks

Number of subjects to have a complete resolution of cutaneous wart

次要结局

  • Regression of Wart at 4 Weeks(4 weeks)
  • Regression of Wart at 8 Weeks(8 weeks)
  • Regression of Wart at 12 Weeks(12 weeks)

研究者

发起方
Stephen P. Merry
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Stephen P. Merry

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验